Jupiter Neurosciences Inc

Research Jupiter Neurosciences Inc (JUNS) on Bullrun: market cap USD 7.62M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerJUNS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.62M
• Financial periodFY2025
• RevenueUSD 21.80K
• Net income-USD 8.64M
• Gross margin80.6%

Valuation Snapshot

latest market cap is USD 7.62M.

About Jupiter Neurosciences Inc

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease;

Frequently asked questions

What is Jupiter Neurosciences Inc's market cap?

Jupiter Neurosciences Inc's market capitalization is USD 7.62M.

What does Jupiter Neurosciences Inc do?

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally.